Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs

New England Journal of Medicine

Volumn 337, Issue 24, 1997, Pages 1726-1731

  Becquemin, Jean Pierre ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TICLOPIDINE;

ADULT; AGED; ARTICLE; BYPASS SURGERY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL BYPASS; FEMOROTIBIAL BYPASS; GOOD CLINICAL PRACTICE; GRAFT OCCLUSION; GRAFT PATENCY; HUMAN; ISCHEMIA; LEG ANGIOGRAPHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; DOUBLE-BLIND METHOD; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SAPHENOUS VEIN; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0030658097     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712113372404     Document Type: Article

References (26)

1. Dalman RL, Taylor LM Jr. Basic data related to infrainguinal revascularization procedures. Ann Vasc Surg 1990;4:309-12.
2. Fuchs JC, Mitchener JS III, Hagen PO. Postoperative changes in autologous vein grafts. Ann Surg 1978;188:1-15.
3. Chesebro JH, Clements IP, Fuster V, et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 1982;307:73-8.
4. Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation 1986;73:227-32.
5. Chesebro JH, Lam JY, Fuster V. The pathogenesis and prevention of aortocoronary vein bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition. J Am Coll Cardiol 1986;8:Suppl B:57B-66B.
6. Lorenz RL, Schacky CV, Weber M, et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation. Lancet 1984;1:1261-4.
7. Kohler TR, Kaufman JL, Kacoyanis G, et al. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 1984; 96:462-6.
8. McCollum C, Alexander C, Kcnchington G, Franks PJ, Greenhalgh R. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J Vasc Surg 1991;13:150-61.
9. Sheehan SJ, Salter MCP, Donaldson DR, Rajah SM, Kester RC. Five year follow up of long-term aspirin/dipyridamole in femoropopliteal Dacron bypass grafts. Br J Surg 1987;74:330. abstract.
10. Rosenthal D, Mittenthal MJ, Ruben DM, et al. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results. Am Surg 1987;53:477-81.
11. Kretschmer GJ, Wenzl E, Wagner O, et al. Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease. Br J Surg 1986;73:689-92.
12. Arcan JC, Blanchard J, Boissel JP, Destors JM, Panak E. Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications. Angiology 1988;39:802-11.
13. Boissel JP, Peyrieux JC, Destors JM. Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs? Thromb Haemost 1989;62:681-5.
14. Janzon L, Bergqvist D, Boberg J, et al. Prevention of myocardial infarction and stroke in patients with intermittent claudication: effects of ticlopidine: results from STIMS, the Swedish Ticlopidine Multicentre Study. J Intern Med 1990;227:301-8. [Erratum, J Intern Med 1990;228: 659.]
15. Bergqvist D, Almgren B, Dickinson JP. Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS). Eur J Vasc Endovasc Surg 1995;10:69-76.
16. Blanchard J, Carreras LO, Kindermans M, EMATAP Group. Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease. Nouv Rev Fr Hematol 1993;35:523-8.
17. Chevigne M, David JL, Rigo P, Limet R. Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study. Ann Thorac Surg 1984;37:371-8.
18. Limet R, David JL, Magotteaux P, Larock MP, Rigo P. Prevention of aorto-coronary bypass graft occlusion: beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. J Thorac Cardiovasc Surg 1987;94:773-83.
19. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980:142. (IARC scientific publications no. 32.)
20. Edmonson RA, Cohen AT, Das SK, Wagner MB, Kakkar VV. Low-molecular weight heparin versus aspirin and dipyridamole after remoropopliteal bypass grafting. Lancet 1994;344:914-8. [Erratum, Lancet 1994; 344:1307]
21. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106. [Erratum, BMJ 1994;308:1540.]
22. Idem. Collaborative overview of randomised trials of antiplatelet therapy. II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159-68.
23. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215-20.
24. Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
25. Watelet J, Cheysson E, Poels D, et al. Pontages fémoro-poplités par veine saphène in situ ou inversée: étude prospective randomisée de 100 cas. Ann Chir Vasc 1987;1:441-52.
26. Ticlid product monograph. Gentilly, France: Sanoti Pharma, 1993.